trial
as of 2026-07-01Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
NCTId NCT02704962
at a glance
Phase 4 · Completed
Enrollment 94 (actual)
Sponsored by Kaohsiung Kai-Suan Psychiatric Hospital
Primary completion 2016-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
94 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2012-01
Primary completion
2016-02
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Drugs
Indications
Sponsors
Kaohsiung Kai-Suan Psychiatric HospitalLead Sponsor
Investigators
2
Ching-Hua Lin, MD, PhDPrincipal Investigator
Cheng-Chung Cheng, MD, PhDStudy Chair
Sites
2 total
Kaohsiung City, TaiwanKaohsiung City, Taiwan
Facts & assertions
4 sourced
Enrollment
94
Phase
PHASE4
Primary Completion Date
2016-02
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person